Tumor Markers

Cancer Antigen 125 (CA-125)

The blood test named for cancer trips for menstruation, pregnancy and fibroids. Here is what a number over 35 actually tells you, and the screening question it can't answer.

Part of the Tumor Markers — see all 11 values together, including Alpha-Fetoprotein, Beta-hCG, Cancer Antigen 15-3.

A cancer antigen that climbs for menstrual periods, pregnancy, and endometriosis. CA-125 is a protein that ovarian tissue and several other tissues shed into the blood, and its name promises a precision the number does not deliver. It behaves like a motion-sensor porch light that flicks on for the wind, the cat, and the mail carrier, not just an intruder. The light works and the trigger is real, but most of what trips it is harmless.

The reference cutoff is 35 U/mL, a value the National Cancer Institute uses as the upper limit of normal (U/mL is the same as kU/L, so a 35 in either unit means the same thing). Above 35 the result gets flagged, and that flag is where the worry starts. Most people who go looking for answers have a number like a 40 or a 50, no symptoms, and a search history full of fear. What the test is actually good at, according to MedlinePlus, is something narrower: checking whether treatment for an already-diagnosed ovarian cancer is working, or whether the cancer has come back.

That gap between what the name implies and what the test does is the whole reason this page exists. A CA-125 over 35 is not a verdict. In a premenopausal body it is often just physiology.

What a CA-125 number usually means

U/mL
Within the reference range 0–35

NCI treats 35 U/mL as the upper limit of normal. A result here is reassuring but not conclusive: MedlinePlus notes a normal CA-125 does not rule out ovarian cancer, because early tumors and some cancers make little of it.

Flagged, often benign Mildly over 35

A modest elevation has many ordinary causes in premenopausal people. The number alone cannot separate them from cancer, which is why it is read alongside symptoms, history and imaging.

Where the test is genuinely useful Tracked over time

In someone with a known ovarian cancer, the direction of travel across repeat tests tells the story. A falling number suggests treatment is working; a rising one prompts a closer look. The trend matters more than any single draw.

What does a high CA-125 mean?

The honest answer is: it depends on who you are. The cutoff of 35 was set to catch ovarian cancer, but the protein is not exclusive to it. MedlinePlus lists a string of benign conditions that raise CA-125, and most of them are common, treatable, and have nothing to do with cancer. That is the impostor problem in one sentence. The marker rises for the intruder and the mail carrier alike, and the blood test cannot tell you which one walked past the sensor.

In premenopausal people the everyday triggers are frequent enough that a high result is more often benign than not. A sample drawn mid-period, an early pregnancy, an endometriosis flare, or a cluster of uterine fibroids can each carry the number past 35 on their own.

What can push CA-125 above 35

  • Menstruation

    A draw timed to a period can read elevated; MedlinePlus lists it as a benign cause.

  • Pregnancy

    Early pregnancy raises CA-125 without any disease present.

  • Endometriosis

    A frequent reason a premenopausal result lands well above the cutoff.

  • Uterine fibroids

  • Pelvic inflammatory disease

  • Liver disease

    A source unrelated to the reproductive tract entirely.

  • Ovarian cancer

    The condition the test was built for, and the reason an unexplained or rising number gets investigated. NCI lists ovarian cancer diagnosis, treatment response and recurrence as its established uses.

This is also why the menopausal status of the person matters so much. After menopause, menstruation, pregnancy and active endometriosis stop driving the number, so an elevation has fewer innocent explanations and a clinician reads it with more concern. The same 50 U/mL means different things in a 32-year-old and a 68-year-old.

Why CA-125 is not a screening test

The most stubborn misconception is that a healthy person can use CA-125 to catch ovarian cancer early. MedlinePlus states plainly that a provider cannot use it to screen someone who is not at high risk, and the evidence behind that is blunt. The U.S. Preventive Services Task Force gives ovarian cancer screening a D recommendation: studies of CA-125, transvaginal ultrasound, or both have not shown a drop in the number of people who die from the disease. In 2016 the FDA went further with a safety communication recommending against currently offered screening tests in any population of women.

Two numbers explain why. In NCI's analysis, CA-125 detected about 56 percent of early-stage ovarian cancers at a fixed specificity, which means it missed close to 44 percent of the cases that mattered most to catch. At the same time the false alarms are not harmless. In one screening trial, 9.6 percent of participants had a false-positive result, 6.2 percent went on to have surgery they did not need, and 1.2 percent had a surgical complication. A test that misses nearly half of early cancers while sending healthy people to the operating room is not a screening tool. It is a monitoring tool wearing a frightening name.

If your CA-125 came back over 35

  1. 1

    Start with the doctor who ordered it

    Ask why the test was run. Monitoring a known condition and investigating a symptom are different situations, and the same number reads differently in each.

  2. 2

    Share the timing and your cycle

    Mention if you were menstruating, might be pregnant, or have endometriosis or fibroids. MedlinePlus lists all of these as benign causes, and they change how the result is read.

  3. 3

    Expect context, not a single verdict

    Clinicians weigh CA-125 against symptoms, a pelvic exam and imaging. A lone number rarely decides anything.

  4. 4

    Ask about repeating it over time

    Because the trend carries more signal than one draw, your doctor may track the value across several tests rather than acting on one.

CA-125 in context

CA-125 sits among the other tumor markers, none of which works as a standalone screen for the average person. It is one entry on a tumor markers panel alongside markers tied to other organs, such as CEA for colorectal and several other cancers, AFP for liver and germ-cell tumors, CA 19-9 for pancreatic disease, and beta-hCG, which rises in pregnancy as well as certain tumors. Each carries the same caveat: the number describes a tissue, not a diagnosis. Other monitoring markers carry their own pitfalls; NSE, for instance, leaks out of ruptured red cells, so a roughly handled tube can fake a high result. Like the breast-cancer marker CA 27-29, CA 125 says far more about its direction across repeated draws than about any one reading against the lab cutoff.

The single most useful habit with CA-125 is to stop reading any one result as a sentence. Its real value shows up in the slope of repeat measurements in someone already under care, which is why a guide to reading tumor markers spends more time on trends than on cutoffs. A 40 today and a 38 next month is a very different story from a 40 climbing to 120, and only the clinician tracking your history can tell which one you are living. The same trend-over-snapshot caution that governs CA 15-3 applies here: one CA 125 reading settles little, while the direction across serial draws carries the signal.

Sources

Written and reviewed by BloodSight Editorial Team · Last updated

Try BloodSight

See your Cancer Antigen 125 on one timeline.

BloodSight calibrates the reference range to your sex, age, and lab — and shows every value across every visit.

Cancer Antigen 125 5 visits
18 U/mL −23
Mar Apr May Jun Jul

In your personal range

Normal ranges

Group Range Unit
Adult Male 0–35 U/mL
Adult Female 0–35 U/mL

Reference ranges may vary by laboratory and individual factors.

Cancer Antigen 125 — Common Questions

Can my period make my CA-125 high, and should I retest after it ends?
Yes. MedlinePlus lists menstruation among the ordinary conditions that raise CA-125, so a sample drawn during a period can read above 35 U/mL with nothing wrong. Whether to repeat the test, and when in your cycle, is a decision for the doctor who ordered it. A single number drawn at a noisy moment rarely settles anything on its own.
My CA-125 is slightly over 35 but I have no symptoms. Do I have ovarian cancer?
Not on the strength of that number. A result a little over 35, such as a 40 or a 50, has many harmless explanations: menstruation, early pregnancy, endometriosis, uterine fibroids, pelvic inflammatory disease and liver disease all push it up, per MedlinePlus. An isolated mild elevation without symptoms is a reason to talk with your doctor about context and timing, not a diagnosis.
Why won't my doctor order a CA-125 to screen me even though I'm worried about ovarian cancer?
Because the major bodies advise against it for people at average risk. The U.S. Preventive Services Task Force gives ovarian cancer screening a D recommendation, meaning CA-125, transvaginal ultrasound, or both have not been shown to lower the chance of dying from the disease. In 2016 the FDA issued a safety communication recommending against currently offered screening tests in any population. CA-125 does its real work monitoring a cancer that has already been diagnosed.
Can a normal CA-125 mean I definitely don't have ovarian cancer?
No. MedlinePlus is explicit that a normal result does not rule out ovarian cancer, because levels can stay low in early stages and not every tumor produces much CA-125. In NCI's review, the test caught roughly 56 percent of early-stage cancers at a set specificity, so it missed close to 44 percent. A reassuring number is information, not an all-clear.
Does endometriosis or fibroids explain a very high CA-125?
They can. MedlinePlus names endometriosis and uterine fibroids among the benign conditions that raise CA-125, and in premenopausal people these are common reasons a result lands well above the cutoff. Your doctor weighs the number against your history, symptoms and imaging rather than reading it in isolation.
Why does CA-125 behave better as a check in postmenopausal women than in premenopausal women?
Most of the benign triggers MedlinePlus lists, menstruation, pregnancy and active endometriosis, belong to the premenopausal years. After menopause those everyday sources of elevation fall away, so a high result has fewer innocent explanations and the number carries more weight. Interpretation still rests with a clinician who knows your full picture.

Disclaimer

This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.

Related Tests

Carcinoembryonic Antigen CEA

Carcinoembryonic antigen is a watch-post, not a search party. Its real job starts after a cancer is found: tracking whether the number creeps back up between scans.

→
Alpha-Fetoprotein AFP

AFP is read as a cancer marker, but a liver healing from hepatitis or cirrhosis raises it too. Here is how to read the number without panic.

→
Cancer Antigen 19-9 CA 19-9

CA 19-9 is the main blood marker doctors track in pancreatic and bile-duct cancers. Its strangest quirk: a sizable minority of people are simply built not to produce it at all.

→
Beta-hCG β-hCG

A single beta-hCG number rarely settles anything in early pregnancy. The read is in the trend between two draws, and the folk rules about slow and fast rises are mostly wrong.

→
Cancer Antigen 15-3 CA 15-3

One CA 15-3 reading rarely settles anything. Built for serial monitoring, the test speaks through its trajectory, not its latest figure.

→
Neuron-Specific Enolase NSE

Neuron-specific enolase tracks small cell lung cancer and neuroblastoma — but it also leaks out of red cells, so a roughly handled tube can fake a high result.

→
Cancer Antigen 27-29 CA 27-29

CA 27-29 is read like a river gauge after a storm. A single waterline tells you almost nothing; whether the line is climbing or receding is the whole message.

→